Detalles de la búsqueda
1.
Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinoma.
Br J Surg
; 108(10): 1207-1215, 2021 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34095952
2.
Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience.
Dis Esophagus
; 33(3)2020 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31313820
3.
Pyloroplasty may reduce weight loss 1 year after esophagectomy.
Dis Esophagus
; 31(3)2018 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29579257
4.
A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer.
Ann Oncol
; 28(9): 2142-2148, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28911091
5.
How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials.
Ann Oncol
; 28(9): 2077-2085, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28430862
6.
Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database.
Ann Surg Oncol
; 24(12): 3683-3691, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28895113
7.
Concordance of studies for nodal staging is prognostic for worse survival in esophageal cancer.
Dis Esophagus
; 27(8): 770-6, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24152134
8.
Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma.
Dis Esophagus
; 27(2): 168-75, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-23621168
9.
Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study.
ESMO Open
; 9(1): 102202, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38118368
10.
Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort.
Ann Oncol
; 24(5): 1262-6, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23247658
11.
Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation.
Ann Oncol
; 24(11): 2854-9, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23994746
12.
A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer.
Ann Oncol
; 24(11): 2844-9, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23975663
13.
Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting.
Dis Esophagus
; 26(7): 708-15, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23350713
14.
Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer.
Ann Oncol
; 23(10): 2638-2642, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22831985
15.
Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis.
Dis Esophagus
; 25(7): 614-22, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22150920
16.
Tislelizumab versus chemotherapy as second-line treatment of advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302): impact on health-related quality of life.
ESMO Open
; 7(4): 100517, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35785595
17.
Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study.
Eur J Cancer
; 127: 150-157, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32014812
18.
Therapy-induced expression of NF-kappaB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiation.
Dis Esophagus
; 22(2): 127-32, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19021681
19.
Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation.
Dis Esophagus
; 22(1): 32-41, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19021684
20.
A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer.
Eur J Cancer
; 108: 17-24, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30592991